Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of SKCPT vs Celecoxib in Knee Osteoarthritis
NCT05930080Phase 3Completed
- Sponsor
- SK Chemicals
- Start
- Jan 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of SKCPT in knee osteoarthritis (OA), sponsored by SK Chemicals. Started Jan 2021; status: completed.
02
Drugs
SKCPT
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05930080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05930080.